Description: NMDA antagonist; selective for NR2A over NR2B
Chemical Name: N-(Cyclohexylmethyl)-2-[(5-[(phenylmethyl)amino]-1,3,4-thiadiazol-2-yl}thio]acetamide
Purity: ≥99% (HPLC)
Biological Activity
Technical Data
Solubility
Calculators
Datasheets
References
Biological Activity
NMDA receptor antagonist, selective for NR1/NR2A (pIC50 = 5.4) over NR1/NR2B.
Technical Data
M. Wt
376.54
Formula
C18H24N4OS2
Storage
Store at +4°C
Purity
≥99% (HPLC)
CAS Number
556803-08-8
PubChem ID
2608149
InChI Key
XBAZPYFIYYCZBO-UHFFFAOYSA-N
Smiles
O=C(NCC2CCCCC2)CSC1=NN=C(NCC3=CC=CC=C3)S1
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Solubility Data
Solvent
Max Conc. mg/mL
Max Conc. mM
Solubility
DMSO
28.24
75
ethanol
3.77
10
Preparing Stock Solutions
The following data is based on the product molecular weight 376.54. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass
1 mg
5 mg
10 mg
1 mM
2.66 mL
13.28 mL
26.56 mL
5 mM
0.53 mL
2.66 mL
5.31 mL
10 mM
0.27 mL
1.33 mL
2.66 mL
50 mM
0.05 mL
0.27 mL
0.53 mL
Molarity Calculator
Molarity Calculator
Calculate the mass, volume, or concentration required for a solution.
Reconstitution Calculator
Reconstitution Calculator
Dilution Calculator
Dilution Calculator
Calculate the dilution required to prepare a stock solution.
Product Datasheets
Certificate of Analysis / Product Datasheet
Safety Datasheet
Select another language:
View SDS
References
References are publications that support the products' biological activity.
Bettiniet al (2010) Identification and characterization of novel NMDA receptor antagonists selective for NR2A- over NR2B-containing receptors. J.Pharmacol.Exp.Ther. 335 644 PMID: 20810618
McKayet al (2012) Direct pharmacological monitoring of the developmental switch in NMDAR subunit composition using TCN 213, a GluN2A-selective, glycine-dependent antagonist. Br.J.Pharmacol. 166 924 PMID: 22022974